| Literature DB >> 35418773 |
Daidai Wang1, Hua Zhang2, Lanfang Du1, Qiangrong Zhai1, Guangliang Hu1, Wei Gao1, Anyi Zhang1, Sa Wang1, Yajuan Hao1, Kaijian Shang1,3, Xueqing Liu1, Yanxia Gao4, Nijiati Muyesai5, Qingbian Ma1.
Abstract
Purpose: Acute aortic syndrome is a constellation of life-threatening medical conditions for which rapid assessment and targeted intervention are important for the prognosis of patients who are at high risk of in-hospital death. The current study aims to develop and externally validate an early prediction mortality model that can be used to identify high-risk patients with acute aortic syndrome in the emergency department. Patients andEntities:
Keywords: acute aortic syndrome; emergency department; risk prediction model
Year: 2022 PMID: 35418773 PMCID: PMC8995175 DOI: 10.2147/IJGM.S357910
Source DB: PubMed Journal: Int J Gen Med ISSN: 1178-7074
Baseline Clinical Characteristics of All Patients with AAS
| Variable | Development Cohort | Validation Cohort | ||
|---|---|---|---|---|
| Survivors | Non-Survivors | Survivors | Non-Survivors | |
| N (%) | 1000 (91.9%) | 88 (8.1%) | 190 (90.5%) | 20 (9.5%) |
| Demographics | ||||
| Age, y | 52.0 [45.0–62.0] | 51.0 [43.0–58.0] | 51.9±14.1 | 60.9±13.0* |
| Male | 774 (77.4%) | 66 (75.0%) | 153 (80.5%) | 13 (65.0%) |
| Stanford type | ||||
| Type A | 603 (60.3%) | 82 (93.2%)* | 70 (36.8%) | 17 (85.0%)* |
| Type B | 397 (39.7%) | 6 (6.8%) | 120 (63.2%) | 3 (15.0%) |
| Clinical type | ||||
| AAD | 901 (90.1%) | 87 (98.9%)* | 174 (91.6%) | 20 (100%) |
| IMH | 85 (8.5%) | 1 (1.1%) | 16 (8.42%) | 0 (0.00%) |
| PAU | 14 (1.4%) | 0 (0.0%) | 0 (0.0%) | 0 (0.00%) |
| Etiology and history | ||||
| Marfan syndrome | 9 (0.9%) | 0 (0.0%) | 3 (1.58%) | 0 (0.00%) |
| Biscuspid aortic valve | 5 (0.5%) | 2 (2.3%) | 1 (0.53%) | 0 (0.00%) |
| Aortic aneurysm | 5 (0.5%) | 1 (1.1%) | 3 (1.58%) | 3 (1.58%) |
| Hypertension | 736 (73.9%) | 68 (77.3%) | 121 (63.7%) | 14 (70.0%) |
| Diabetes | 39 (3.9%) | 4 (4.6%) | 4 (2.11%) | 2 (10.0%) |
| Coronary heart disease | 50 (5.0%) | 6 (6.9%)* | 14 (7.37%) | 3 (15.0%) |
| Chronic renal insufficiency | 26 (2.6%) | 3 (3.4%)* | 8 (4.21%) | 1 (5.00%) |
| Prior cardiac surgery | 12 (1.2%) | 1 (1.1%) | 0 (0%) | 0 (0%) |
| Clinical presentations and signs | ||||
| Chest pain | 778 (77.8%) | 78 (88.6%)* | 92 (48.4%) | 14 (70.0%) |
| Back pain | 696 (69.6%) | 68 (77.3%) | 74 (38.9%) | 9 (45.0%) |
| Abdominal pain | 200 (20.0%) | 29 (33.0%)* | 70 (36.8%) | 6 (30.0%) |
| Abrupt pain | 946 (98.8%) | 84 (98.4%) | 188 (98.9%) | 19 (95.0%) |
| Palpitation | 193 (19.3%) | 30 (34.1%)* | 8 (4.21%) | 3 (15.0%) |
| Sweating | 389 (38.9%) | 57 (64.8%)* | 61 (32.1%) | 11 (55.0%) |
| Dyspnea | 173 (17.3%) | 29 (33.0%)* | 24 (12.6%) | 3 (15.0%) |
| Digestive system symptoms | 431 (43.1%) | 54 (61.4%)* | 39 (20.5%) | 9 (45.0%)* |
| Central nervous system symptoms | 117 (11.7%) | 17 (19.3%)* | 14 (7.37%) | 8 (40.0%)* |
| Limb involved symptoms | 84 (8.4%) | 13 (14.8%)* | 18 (9.47%) | 4 (20.0%) |
| Mean SBP, mm Hg | 147 [129–164] | 134 [112–163]* | 155±35.2 | 128±43.0* |
| Any pulse deficit | 52 (5.2%) | 19 (21.8%)* | 11 (5.79%) | 2 (10.0%) |
| Laboratory data | ||||
| White blood cell count (109/L) | 11.5 [9.09–14.1] | 13.2 [10.7–17.8]* | 11.4 [9.03–14.6] | 13.8 [11.1–19.8]* |
| Neutrophil count (109/L) | 9.78 [7.31–12.4] | 11.5 [9.54–15.4]* | 9.15 [6.20–12.6] | 11.8 [8.06–17.3]* |
| Lymphocyte count (109/L) | 0.94 [0.67–1.32] | 0.99 [0.73–1.33] | 1.52±1.02 | 1.75±1.13 |
| Platelet (1012/L) | 178 [143–220] | 180 [143–212] | 189 [156–226] | 168 [133–187] |
| Hemoglobin (g/L) | 135 [122–146] | 140 [124–153] | 138±23.4 | 129±20.6 |
| Total bilirubin (umol/L) | 14.9 [10.9–20.9] | 18.5 [14.5–27.3]* | 16.8 [11.8–23.9] | 13.1 [9.05–22.5] |
| Creatinine (umol/L) | 76.0 [62.2–96.0] | 97.6 [68.5–141]* | 83.0 [66.0–110] | 97.0 [80.0–127] |
| PT (s) | 12.6 [11.1–14.2] | 14.7 [13.7–16.4]* | 11.6 [10.8–12.4] | 12.1 [11.5–13.1]* |
| APTT (s) | 32.3 [28.4–38.3] | 38.7 [36.1–42.3]* | 30.7 [28.2–34.6] | 30.0 [28.1–31.7] |
| INR | 1.05 [0.99–1.13] | 1.15 [1.09–1.34]* | 1.07 [1.01–1.15] | 1.12 [1.07–1.22]* |
| D-dimer (µg/mL) | 2.60 [1.02–6.96] | 8.73 [4.78–13.9]* | 2.02 [0.80–6.04] | 9.60 [3.33–27.2]* |
| Aortic CT angiography | ||||
| Branch vessel involvement | ||||
| Coronary artery involvement | 20 (2.3%) | 2 (2.8%) | 3 (1.58%) | 2 (10.0%) |
| Brachiocephalic trunk involvement | 90 (10.5%) | 14 (19.7%)* | 21 (11.1%) | 7 (35.0%)* |
| Celiac trunk involvement | 118 (13.8%) | 14 (19.7%) | 118 (13.8%) | 14 (19.7%) |
| Renal artery involvement | 158 (18.4%) | 18 (25.4%) | 158 (18.4%) | 18 (25.4%) |
| Lesion extension to iliac vessels | 214 (24.9%) | 32 (44.4%)* | 67 (7.81%) | 5 (7.04%) |
| Abdominal organ involvement | 196 (22.8%) | 27 (38.0%) | 196 (22.8%) | 27 (38.0%)* |
| Pleural effusion | 260 (33.4%) | 15 (26.3%) | 260 (30.3%) | 15 (21.1%) |
| Pericardial effusion | 123 (15.6%) | 22 (37.9%) | 125 (14.6%) | 22 (31.0%)* |
Note: *p<0.05.
Abbreviations: AAD, acute aortic dissection; IMH, intramural hematoma; PAU, penetrating atherosclerotic aortic ulcer; AAS, acute aortic syndromes; ED, emergency department; SBP, systolic blood pressure; PT, prothrombin time; APTT, activated partial thromboplastin time; INR, international normalised ratio.
Multivariate Logistic Regression of Predictive Variables with In-Hospital Death
| Variable | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| p | OR (95% CI) | p | OR (95% CI) | |
| Digestive system symptoms | 0.001 | 2.10[1.34,3.28] | 0.024 | 2.25[1.11,4.53] |
| Any pulse deficit | <0.001 | 5.07[2.84,9.06] | <0.001 | 7.78[2.94,20.63] |
| Creatinine (µmol/L) | <0.001 | 1.00[1.00,1.00] | 0.018 | 1.00[1.00,1.00] |
| Lesion extension to iliac vessels | <0.001 | 2.41[1.48,3.93] | <0.001 | 4.49[2.33,8.64] |
| Pericardial effusion | <0.001 | 3.31[1.88,5.82] | 0.008 | 2.67[1.29,5.53] |
| Stanford type A | <0.001 | 9.00[3.89,20.81] | <0.001 | 10.46[3.31,33.1] |
Abbreviations: Cr, creatinine; CI, confidence interval; OR, odds ratio.
Figure 1(A) ROC of the model: the AUC (C index) was 0.838 (95% range 0.784–0.892). (B) Calibration curves for the prediction model.
Figure 2ROC of the model in validation cohort: the AUC (C index) was 0.821 (95% range 0.750–0.891).
Figure 3In the nomogram for bedside application, we assigned values to each of the variables based on the multivariable regression results. To use this nomogram, first locate whether the patient has any pulse deficit, then draw a line straight up to the Points axis on the top to obtain the score associated with pulse deficit. Repeat the process for the other covariates (from age to Stanford type A). Add the scores of the covariates together and locate the total score on the Total Points axis just below the last covariate. Next, draw a line straight down to the Risk of Death axis at the bottom to obtain the probability.